Zai Lab Limited ADR (NASDAQ: ZLAB) kicked off on Monday, up 3.36% from the previous trading day, before settling in for the closing price of $27.97. Over the past 52 weeks, ZLAB has traded in a range of $13.48-$36.60.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Annual sales at Healthcare sector company grew by 2095.12% over the past five years. While this was happening, its average annual earnings per share was recorded 21.57%. With a float of $107.88 million, this company’s outstanding shares have now reached $108.14 million.
Let’s look at the performance matrix of the company that is accounted for 2175 employees. In terms of profitability, gross margin is 63.17%, operating margin of -95.07%, and the pretax margin is -76.13%.
Zai Lab Limited ADR (ZLAB) Insider and Institutional Ownership
Our next focus will be how large-scale investors are participating in this stock of the Biotechnology Industry. The insider ownership of Zai Lab Limited ADR is 0.24%, while institutional ownership is 43.92%. The most recent insider transaction that took place on Nov 04 ’24, was worth 5,121. In this transaction Chief Financial Officer of this company sold 167 shares at a rate of $30.66, taking the stock ownership to the 15,494 shares. Before that another transaction happened on Nov 04 ’24, when Company’s Officer proposed sale 167 for $30.66, making the entire transaction worth $5,121.
Zai Lab Limited ADR (ZLAB) Latest Financial update
According to the Wall Street analysts, stocks earnings will be around 21.57% per share during the next fiscal year.
Zai Lab Limited ADR (NASDAQ: ZLAB) Trading Performance Indicators
Take a look at Zai Lab Limited ADR’s (ZLAB) current performance indicators. Last quarter, stock had a quick ratio of 2.87. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 8.79.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.78, a number that is poised to hit -0.70 in the next quarter and is forecasted to reach -1.77 in one year’s time.
Technical Analysis of Zai Lab Limited ADR (ZLAB)
Zai Lab Limited ADR (NASDAQ: ZLAB) saw its 5-day average volume 0.75 million, a positive change from its year-to-date volume of 0.72 million. As of the previous 9 days, the stock’s Stochastic %D was 49.32%. Additionally, its Average True Range was 1.59.
During the past 100 days, Zai Lab Limited ADR’s (ZLAB) raw stochastic average was set at 62.65%, which indicates a significant decrease from 71.56% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 47.72% in the past 14 days, which was lower than the 59.07% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $28.01, while its 200-day Moving Average is $20.73. Nevertheless, the first resistance level for the watch stands at $29.64 in the near term. At $30.37, the stock is likely to face the second major resistance level. The third major resistance level sits at $30.86. If the price goes on to break the first support level at $28.41, it is likely to go to the next support level at $27.92. The third support level lies at $27.19 if the price breaches the second support level.
Zai Lab Limited ADR (NASDAQ: ZLAB) Key Stats
The company with the Market Capitalisation of 3.13 billion has total of 108,628K Shares Outstanding. Its annual sales at the moment are 266,720 K in contrast with the sum of -334,620 K annual income. Company’s last quarter sales were recorded 102,270 K and last quarter income was -41,670 K.
